CRL logo

CRL Cash From Financing

Annual CFF:

-$550.93M-$465.41M(-544.20%)
December 31, 2024

Summary

  • As of today, CRL annual cash from financing is -$550.93 million, with the most recent change of -$465.41 million (-544.20%) on December 31, 2024.
  • During the last 3 years, CRL annual cash from financing has fallen by -$1.22 billion (-181.91%).
  • CRL annual cash from financing is now -181.91% below its all-time high of $672.60 million, reached on December 25, 2021.

Performance

CRL Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLcash flow metrics

Quarterly CFF:

-$152.62M+$93.44M(+37.98%)
September 27, 2025

Summary

  • As of today, CRL quarterly cash from financing is -$152.62 million, with the most recent change of +$93.44 million (+37.98%) on September 27, 2025.
  • Over the past year, CRL quarterly cash from financing has increased by +$54.92 million (+26.46%).
  • CRL quarterly cash from financing is now -121.21% below its all-time high of $719.51 million, reached on June 30, 2018.

Performance

CRL Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLcash flow metrics

TTM CFF:

-$560.74M+$54.92M(+8.92%)
September 27, 2025

Summary

  • As of today, CRL TTM cash from financing is -$560.74 million, with the most recent change of +$54.92 million (+8.92%) on September 27, 2025.
  • Over the past year, CRL TTM cash from financing has dropped by -$209.26 million (-59.54%).
  • CRL TTM cash from financing is now -167.37% below its all-time high of $832.34 million, reached on September 25, 2021.

Performance

CRL TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CRL Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-544.2%+26.5%-59.5%
3Y3 Years-181.9%-195.8%-4417.4%
5Y5 Years-337.5%+43.2%-931.5%

CRL Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-181.9%at low-223.5%+46.6%>-9999.0%+14.4%
5Y5-Year-181.9%at low-129.5%+46.6%-167.4%+14.4%
All-TimeAll-Time-181.9%at low-121.2%+46.6%-167.4%+14.4%

CRL Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$152.62M(+38.0%)
-$560.74M(+8.9%)
Jun 2025
-
-$246.06M(-185.5%)
-$615.66M(+6.1%)
Mar 2025
-
-$86.19M(-13.6%)
-$655.46M(-19.0%)
Dec 2024
-$550.93M(-544.2%)
-$75.88M(+63.4%)
-$550.93M(-56.7%)
Sep 2024
-
-$207.54M(+27.4%)
-$351.48M(-14.6%)
Jun 2024
-
-$285.86M(-1658.1%)
-$306.81M(-232.0%)
Mar 2024
-
$18.35M(-85.2%)
-$92.42M(-8.1%)
Dec 2023
-$85.52M(-101.7%)
-
-
Dec 2023
-
$123.57M(+175.9%)
-$85.52M(+81.3%)
Sep 2023
-
-$162.87M(-127.9%)
-$458.05M(-32.1%)
Jun 2023
-
-$71.46M(-383.1%)
-$346.77M(-8853.6%)
Mar 2023
-
$25.24M(+110.1%)
-$3.87M(+90.9%)
Dec 2022
-$42.40M(-106.3%)
-$248.96M(-382.5%)
-$42.40M(-241.6%)
Sep 2022
-
-$51.59M(-119.0%)
-$12.41M(-105.7%)
Jun 2022
-
$271.44M(+2143.5%)
$218.08M(-53.1%)
Mar 2022
-
-$13.28M(+93.9%)
$464.60M(-30.9%)
Dec 2021
$672.60M(+1323.5%)
-$218.97M(-222.4%)
$672.60M(-19.2%)
Sep 2021
-
$178.90M(-65.5%)
$832.34M(+116.3%)
Jun 2021
-
$517.96M(+166.0%)
$384.81M(+262.2%)
Mar 2021
-
$194.72M(+428.8%)
-$237.24M(-602.1%)
Dec 2020
$47.25M(-79.6%)
-$59.23M(+78.0%)
$47.25M(-29.9%)
Sep 2020
-
-$268.64M(-158.1%)
$67.43M(-66.7%)
Jun 2020
-
-$104.10M(-121.7%)
$202.63M(-74.0%)
Mar 2020
-
$479.21M(+1327.4%)
$780.23M(+236.4%)
Dec 2019
$231.94M(-58.4%)
-$39.04M(+70.7%)
$231.94M(-14.6%)
Sep 2019
-
-$133.44M(-128.2%)
$271.54M(+5.3%)
Jun 2019
-
$473.51M(+785.4%)
$257.91M(-48.8%)
Mar 2019
-
-$69.08M(>-9900.0%)
$503.91M(-9.7%)
Dec 2018
$558.06M(+367.7%)
$563.00K(+100.4%)
$558.06M(+10.6%)
Sep 2018
-
-$147.08M(-120.4%)
$504.49M(-22.5%)
Jun 2018
-
$719.51M(+4917.3%)
$651.16M(+536.8%)
Mar 2018
-
-$14.94M(+71.8%)
-$149.09M(+28.5%)
Dec 2017
-$208.48M(-153.4%)
-$53.01M(>-9900.0%)
-$208.48M(-16.5%)
Sep 2017
-
-$402.00K(+99.5%)
-$178.93M(+36.9%)
Jun 2017
-
-$80.74M(-8.6%)
-$283.72M(-191.7%)
Mar 2017
-
-$74.32M(-216.7%)
$309.32M(-20.8%)
Dec 2016
$390.73M(+8491.2%)
-$23.46M(+77.7%)
$390.73M(-9.2%)
Sep 2016
-
-$105.19M(-120.5%)
$430.18M(-26.8%)
Jun 2016
-
$512.30M(+7134.8%)
$587.65M(+5961.4%)
Mar 2016
-
$7.08M(-55.7%)
$9.70M(+113.2%)
Dec 2015
$4.55M(-92.6%)
$15.99M(-69.4%)
$4.55M(-19.9%)
Sep 2015
-
$52.29M(+179.6%)
$5.68M(+107.1%)
Jun 2015
-
-$65.66M(-3495.1%)
-$80.53M(-215.9%)
Mar 2015
-
$1.93M(-88.7%)
$69.49M(+13.2%)
Dec 2014
$61.41M(+172.9%)
$17.12M(+150.5%)
$61.41M(+116.3%)
Sep 2014
-
-$33.92M(-140.2%)
$28.39M(+21.4%)
Jun 2014
-
$84.36M(+1473.0%)
$23.39M(+127.9%)
Mar 2014
-
-$6.14M(+61.4%)
-$83.87M(+0.4%)
Dec 2013
-$84.24M(+24.2%)
-$15.91M(+59.1%)
-$84.24M(+2.6%)
Sep 2013
-
-$38.91M(-69.9%)
-$86.44M(-15.2%)
Jun 2013
-
-$22.91M(-251.9%)
-$75.07M(+13.7%)
Mar 2013
-
-$6.51M(+64.1%)
-$87.00M(+21.7%)
Dec 2012
-$111.12M
-$18.11M(+34.2%)
-$111.12M(+25.4%)
DateAnnualQuarterlyTTM
Sep 2012
-
-$27.54M(+21.0%)
-$149.02M(+34.5%)
Jun 2012
-
-$34.84M(-13.7%)
-$227.62M(+16.7%)
Mar 2012
-
-$30.64M(+45.3%)
-$273.16M(-0.5%)
Dec 2011
-$271.79M(-61.8%)
-$56.01M(+47.2%)
-$271.79M(-18.1%)
Sep 2011
-
-$106.14M(-32.1%)
-$230.19M(-7.4%)
Jun 2011
-
-$80.38M(-174.7%)
-$214.39M(-23.2%)
Mar 2011
-
-$29.26M(-102.9%)
-$173.98M(-3.6%)
Dec 2010
-$167.96M(-107.4%)
-$14.42M(+84.0%)
-$167.96M(-3.8%)
Sep 2010
-
-$90.34M(-126.0%)
-$161.84M(-62.2%)
Jun 2010
-
-$39.97M(-72.0%)
-$99.75M(-51.2%)
Mar 2010
-
-$23.24M(-179.8%)
-$65.99M(+18.5%)
Dec 2009
-$80.98M(-367.5%)
-$8.30M(+70.6%)
-$80.98M(-26.9%)
Sep 2009
-
-$28.24M(-355.4%)
-$63.81M(-82.5%)
Jun 2009
-
-$6.20M(+83.8%)
-$34.97M(+15.6%)
Mar 2009
-
-$38.23M(-531.2%)
-$41.44M(-139.3%)
Dec 2008
-$17.32M(+62.7%)
$8.87M(+1377.5%)
-$17.32M(+44.9%)
Sep 2008
-
$600.00K(+104.7%)
-$31.44M(+45.9%)
Jun 2008
-
-$12.68M(+10.1%)
-$58.10M(-42.6%)
Mar 2008
-
-$14.11M(-168.5%)
-$40.73M(+12.3%)
Dec 2007
-$46.43M(-933.8%)
-$5.25M(+79.8%)
-$46.43M(+31.9%)
Sep 2007
-
-$26.06M(-655.6%)
-$68.16M(+44.9%)
Jun 2007
-
$4.69M(+123.7%)
-$123.66M(-371.5%)
Mar 2007
-
-$19.80M(+26.6%)
-$26.23M(-571.0%)
Dec 2006
$5.57M(+102.9%)
-$26.98M(+66.9%)
$5.57M(+109.2%)
Sep 2006
-
-$81.56M(-179.9%)
-$60.52M(-3926.5%)
Jun 2006
-
$102.12M(+751.4%)
-$1.50M(+99.1%)
Mar 2006
-
$11.99M(+112.9%)
-$171.33M(+12.2%)
Dec 2005
-$195.24M(-144.7%)
-$93.07M(-312.7%)
-$195.24M(-159.8%)
Sep 2005
-
-$22.55M(+66.7%)
$326.65M(-7.0%)
Jun 2005
-
-$67.70M(-468.0%)
$351.21M(-16.5%)
Mar 2005
-
-$11.92M(-102.8%)
$420.67M(-3.7%)
Dec 2004
$436.95M(+5069.8%)
$428.82M(>+9900.0%)
$436.95M(>+9900.0%)
Sep 2004
-
$2.01M(+14.5%)
-$2.14M(-275.3%)
Jun 2004
-
$1.76M(-59.6%)
$1.22M(+152.2%)
Mar 2004
-
$4.36M(+142.4%)
-$2.34M(+73.4%)
Dec 2003
-$8.79M(-269.9%)
-$10.27M(-291.0%)
-$8.79M(-4188.8%)
Sep 2003
-
$5.38M(+398.1%)
-$205.00K(+93.4%)
Jun 2003
-
-$1.80M(+14.0%)
-$3.09M(+95.7%)
Mar 2003
-
-$2.10M(-24.8%)
-$72.17M(-1494.7%)
Dec 2002
$5.17M(-89.0%)
-$1.68M(-167.4%)
$5.17M(+116.2%)
Sep 2002
-
$2.49M(+103.5%)
-$31.92M(-423.7%)
Jun 2002
-
-$70.89M(-194.2%)
$9.86M(-70.8%)
Mar 2002
-
$75.25M(+294.1%)
$33.82M(-28.4%)
Dec 2001
$47.23M(+5939.6%)
-$38.77M(-187.6%)
$47.23M(-44.6%)
Sep 2001
-
$44.27M(+194.3%)
$85.29M(+111.5%)
Jun 2001
-
-$46.93M(-152.9%)
$40.33M(-53.0%)
Mar 2001
-
$88.66M(>+9900.0%)
$85.72M(>+9900.0%)
Dec 2000
$782.00K(+109.8%)
-$711.00K(-2.9%)
$782.00K(-47.6%)
Sep 2000
-
-$691.00K(+55.0%)
$1.49M(-31.6%)
Jun 2000
-
-$1.54M(-141.3%)
$2.18M(-41.3%)
Mar 2000
-
$3.72M
$3.72M
Dec 1998
-$8.02M(+38.0%)
-
-
Dec 1997
-$12.94M
-
-

FAQ

  • What is Charles River Laboratories International, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Charles River Laboratories International, Inc.?
  • What is Charles River Laboratories International, Inc. annual cash from financing year-on-year change?
  • What is Charles River Laboratories International, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Charles River Laboratories International, Inc.?
  • What is Charles River Laboratories International, Inc. quarterly cash from financing year-on-year change?
  • What is Charles River Laboratories International, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Charles River Laboratories International, Inc.?
  • What is Charles River Laboratories International, Inc. TTM cash from financing year-on-year change?

What is Charles River Laboratories International, Inc. annual cash from financing?

The current annual cash from financing of CRL is -$550.93M

What is the all-time high annual cash from financing for Charles River Laboratories International, Inc.?

Charles River Laboratories International, Inc. all-time high annual cash from financing is $672.60M

What is Charles River Laboratories International, Inc. annual cash from financing year-on-year change?

Over the past year, CRL annual cash from financing has changed by -$465.41M (-544.20%)

What is Charles River Laboratories International, Inc. quarterly cash from financing?

The current quarterly cash from financing of CRL is -$152.62M

What is the all-time high quarterly cash from financing for Charles River Laboratories International, Inc.?

Charles River Laboratories International, Inc. all-time high quarterly cash from financing is $719.51M

What is Charles River Laboratories International, Inc. quarterly cash from financing year-on-year change?

Over the past year, CRL quarterly cash from financing has changed by +$54.92M (+26.46%)

What is Charles River Laboratories International, Inc. TTM cash from financing?

The current TTM cash from financing of CRL is -$560.74M

What is the all-time high TTM cash from financing for Charles River Laboratories International, Inc.?

Charles River Laboratories International, Inc. all-time high TTM cash from financing is $832.34M

What is Charles River Laboratories International, Inc. TTM cash from financing year-on-year change?

Over the past year, CRL TTM cash from financing has changed by -$209.26M (-59.54%)
On this page